SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001047469-18-000858
Filing Date
2018-02-16
Accepted
2018-02-16 17:07:19
Documents
3
Period of Report
2018-03-21

Document Format Files

Seq Description Document Type Size
1 PRE 14A a2234563zpre14a.htm PRE 14A 118091
2 G29732BGI001.GIF g29732bgi001.gif GRAPHIC 89233
3 G29732BGI002.GIF g29732bgi002.gif GRAPHIC 112632
  Complete submission text file 0001047469-18-000858.txt   397424
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36020 | Film No.: 18622074
SIC: 2834 Pharmaceutical Preparations